SEC Filing Summary: Zimmer Holdings, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on September 10, 2004. The report discloses a material modification to the rights of security holders approved by the Board of Directors on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder rights rather than financial performance.
Material Changes
- Expiration of Rights Plan: The Company approved Amendment No. 2 to its Rights Agreement with Mellon Investor Services LLC.
- Accelerated Expiration: The Rights will expire on September 16, 2004, which is more than six years earlier than the date initially specified in the original agreement dated July 30, 2001.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future operations, or specific risk factors. The primary action is the removal of the poison pill provision (Rights) via early expiration. A press release issued in connection with this amendment is referenced as Exhibit 99.1.
Key Facts for Investor Verification
- Confirm the effective expiration date of the Rights Agreement is September 16, 2004.
- Review the attached Amendment No. 2 (Exhibit 4.1) for specific terms regarding the termination of the Rights.
- Verify the rationale for the early expiration in the referenced press release (Exhibit 99.1).